Navigation Links
Body Shaping Fuels Growth of $5.2 Billion Global Medical Aesthetic Market
Date:8/4/2008

ALISO VIEJO, Calif., Aug. 4 /PRNewswire/ -- Over the next five years, new body shaping and skin tightening technologies will drive double-digit growth in the global aesthetic industry, according to the just-released Global Aesthetic Market V research report from Medical Insight, Inc.

The GAM V study, which is the only published report providing comprehensive and in-depth global analysis of the entire $5.2 billion aesthetic industry, describes in detail how these relatively new categories will play prominent roles in escalating industry sales, projected to reach $8.9 billion by 2012. Among highlights in the fifth edition of this semi-annual forecast:

-- Body Shaping, the larger of the two businesses, will grow from $384.5 million in global supplier sales to $809.6 million by 2012, for 22.7% annual growth;

-- Skin Tightening will expand from $110.7 million in equipment revenues to $206 million in 2012, reflecting 18.9% annual growth;

-- Energy-based devices will earn manufacturers more than $1.6 billion in 2012, growing by 6.3% per year from $1.1 billion in 2008 after a slight decline in early 2008.

"Although the aesthetic device industry experienced a contraction in the first two quarters of 2008 due to a weaker U.S. economy with reduced spending, the body shaping and skin tightening sectors will drive overall growth of 13% per year in the aesthetic market," said Michael Moretti, president of Medical Insight, Inc. and editor of the GAM V study. "These two sets of technologies address a major problem associated with aging that until now, has not been solved. Combined, these two segments will represent more than $9 billion in physician fees and over $1 billion in device sales revenues by 2012."

Public companies detailed in GAM V include Allergan, Bioform, Candela, Cutera, Cynosure, Medicis, Mentor, Obagi, Palomar, Syneron, Thermage and more than three dozen others, including the leading startup players.

GAM V provides critical information on every product and procedure segment of the medical aesthetic industry. For more information and to preview a table of contents and Executive Summary, visit http://www.miinews.com.

About Medical Insight, Inc.

Medical Insight, Inc. is the industry leader in syndicated and custom research for the aesthetic market. Under the leadership of Michael Moretti, Medical Insight Inc. has collected data for over 20 years on procedure volume, revenues, product sales, new product introductions, market forecasts and trends, delivering detailed analyses that are used by many of the industry's top decision makers.

Contact: Medical Insight, Inc.

Michael Moretti, 949/830-5409

Email: mmoretti@MiiNews.com


'/>"/>
SOURCE Medical Insight, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New Generation Biofuels Set to Join Russell Microcap Index
2. NexGen Biofuels Ltd. Announces Plans to Replace its CFO With Local CFO
3. Performance Plants Establishes U.S. Biofuels Facility
4. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
5. Science Fuels DNA Testing Controversy with Prejudicial Misquote
6. Nova Biosource Fuels Expands Senior Executive Team
7. NexGen Biofuels Ltd. Announces Trading on OTC Bulletin Board
8. Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility
9. NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination
10. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
11. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):